BSX · News · 20260917N

Competition and Market Share

BOSTON SCIENTIFIC CORP · 2026-09-17 · Importance 20 · Surprise 24

Boston Scientific faces near-term pressure in electrophysiology as Medtronic reportedly gains share and shows stronger momentum across key franchises. Citi also cited increased competition in pulsed field ablation, where competitive intensity is pressuring Boston Scientific’s recovery path. The atrial appendage closure market was described as stagnating, while urology issues added to pressure on key growth drivers.

Key facts

• Boston Scientific faces near-term pressure in electrophysiology. source
• Citi cited increased competition in pulsed field ablation as a setback for Boston Scientific in 2026. source
• Citi cited a stagnating atrial appendage closure market as a setback for Boston Scientific in 2026. source
• Citi cited urology issues as a setback for Boston Scientific in 2026. source